Clinical Trial Update: SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

View source ↗

Summary

Clinical trial update states that the SeQuent SCB PMCF study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• SeQuent SCB (paclitaxel-coated balloon)

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Coronary Artery Disease, Myocardial Ischaemia | Status: ACTIVE_NOT_RECRUITING